We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.
- Authors
Esteva, Francisco J; Valero, Vicente; Booser, Daniel; Guerra, Laura T; Murray, James L; Pusztai, Lajos; Cristofanilli, Massimo; Arun, Banu; Esmaeli, Bita; Fritsche, Herbert A; Sneige, Nour; Smith, Terry L; Hortobagyi, Gabriel N
- Abstract
To evaluate the safety and efficacy of weekly docetaxel plus trastuzumab in women with HER-2-overexpressing metastatic breast cancer. Efficacy was correlated with serum HER-2 extracellular domain (ECD) levels.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 7, p1800
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.07.058